DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0699791 | Stomach Carcinoma | GALNT1 | 2589 | polypeptide N-acetylgalactosaminyltransferase 1 | Q10472 |
C0024623 | Malignant neoplasm of stomach | GALNT1 | 2589 | polypeptide N-acetylgalactosaminyltransferase 1 | Q10472 |
C0018824 | Heart valve disease | GALNT1 | 2589 | polypeptide N-acetylgalactosaminyltransferase 1 | Q10472 |
C0020538 | Hypertensive disease | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0085413 | Polycystic Kidney, Autosomal Dominant | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0022661 | Kidney Failure, Chronic | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C2751306 | Polycystic kidney disease, type 2 | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C4552000 | Episodic Kinesigenic Dyskinesia 1 | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C3887499 | Renal cyst | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0022680 | Polycystic Kidney Diseases | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0006826 | Malignant Neoplasms | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0085548 | Autosomal Recessive Polycystic Kidney Disease | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0027651 | Neoplasms | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0022658 | Kidney Diseases | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0003868 | Arthritis, Gouty | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0158683 | Polycystic liver disease | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0376358 | Malignant neoplasm of prostate | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C3149841 | POLYCYSTIC KIDNEY DISEASE 1 | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0280324 | Laryngeal Squamous Cell Carcinoma | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0031511 | Pheochromocytoma | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0032580 | Adenomatous Polyposis Coli | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0018802 | Congestive heart failure | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0887850 | Polycystic Kidney, Type 1 Autosomal Dominant Disease | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C0699885 | Carcinoma of bladder | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
C1306459 | Primary malignant neoplasm | PKD2 | 5311 | polycystin 2, transient receptor potential cation channel | Q13563 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024